Recorded Presentation from the 2015 NCCN Oncology Case Manager and Medical Director Program™ - Challenges in Assessing and Using Biomarkers in Oncology Care

The 2015 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of melanoma, biomarkers, management of cancer in older patients with comorbidities, managing symptoms and reducing complications, and two sessions on less common and complex cancers. This educational series is designed to help case managers and medical directors that are interested in learning more about the current state of the art in oncology care manage patients with cancer based on evidence and according to the recommendations in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).

Target Audience

This educational program is designed to meet the educational needs of nurse case managers, nurses in other roles (i.e., quality management and utilization review), medical directors at managed care organizations, reinsurers, TPAs, and case management and disease management companies who interact with, counsel, and refer patients with cancer to appropriate sources of care and/or make coverage decisions. Programs may also be of interest to nurses, nurse navigators/care coordinators, and physicians who work directly with patients in clinical settings as well as clinical pharmacists in managed care organizations and other settings.

Learning Objectives

Following this activity, participants should be able to:

  • Explain the benefits and drawbacks of multiplex mutation testing
  • List several factors to consider when determining the type of biomarker testing to utilize
  • Describe the type of data needed before a biomarker should be used to match a patient with a treatment
Additional information
Supporters: 

This activity is supported by educational grants from: 

  • AstraZeneca
  • Astellas Scientific and Medical Affairs, Inc. and Medivation
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Merck

Supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Course summary
Available credit: 
  • 1.00 Case Manager
  • 1.00 Participation
  • 1.02 Nurse
  • 1.00 Physician
Course opens: 
10/07/2015
Course expires: 
10/07/2016
Cost:
$0.00

Wallace Akerley, MD
Huntsman Cancer Institute at the University of Utah

Available Credit

  • 1.00 Case Manager
  • 1.00 Participation
  • 1.02 Nurse
  • 1.00 Physician

Accreditation Period

Course opens: 
10/07/2015
Course expires: 
10/07/2016

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Flash Player and/or an HTML5 capable browser for video or audio playback
  • For Windows: JavaScript and cookies enabled, Active X enabled and unblocked for Microsoft Internet Explorer, Java 6.0 or above
  • For Mac: JavaScript and cookies enabled, Plug-ins enabled in Safari, Java 6.0 or above
  • Adobe Reader or other PDF reader software for certificate viewing/printing